Novartis vet named CMO at Rgenix; Ophthotech promotes Sblendorio to CEO spot
→ UCSF hired Harold “Barry” Sellick as its new vice chancellor to nurture inventions and bring new products to the market at a more advanced stage. And to that end he will supervise proof-of-concept studies for a range of drugs and devices.
→ Teva announced the exit of longtime CFO Eyal Desheh, feeding into speculation regarding the top-to-bottom reorganization of the company after generic drug prices began to erode.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.